Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Rockefeller University scientists delve into the genetic roots of addiction

Aug. 12, 1998

Vigabatrin is effective for treating alcohol withdrawal syndrome

July 22, 1998

GV-150013 has dual therapeutic potential in treating alcoholism and sleep disorders

July 22, 1998

Calcium channel blockers reduce craving for alcohol

July 21, 1998

FDA accepts license applications for CroTAb

July 20, 1998

Dopamine transporter ligand shows potential in cocaine abuse

July 17, 1998

NeuroSearch begins phase I trial for cocaine addiction treatment

June 12, 1998

Habitrol transdermal nicotine patch soon to be available over the counter in Canada

May 27, 1998

Dextrose in combination with nicotine patches may aid in smoking cessation

May 21, 1998

New evidence supports the role of genetics in drug addiction

May 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...